The Epigenetics 2019

Sep 09-10, 2019

London, United Kingdom

Conference in 2019 on Genetics Research: Epigenetics


Lexis Conferences proudly announced the conference The Epigenetics 2019, London which is going to take place in UK during September 9-10, 2019. Lexis invites the conventioneer from around the globe to attend Epigenetics 2019 with the Theme “New insights in Gene Expression” to explore your research work and to gain knowledge from experts.

Epigenetics Conferences 2019 will incorporate incite keynote presentations/Plenary talks, workshops, symposiums, special sessions, poster presentations, Video sessions, and exhibitions. This trending topic needs an exchange of ideas, discussions, and debates to reach the new dimension in the topic. Epigenetics 2019 is a platform to showcase your abilities to the competitive world. Participants will find out around a few themes pertinent to epigenetics and find out about the latest epigenetic studies.


Epigenetics is an extension of genetics and developmental biology, which involves the study of cellular and physiological trait variations initiated by external or environmental stimuli. Epigenetics deals with changes in gene expression caused by certain base pairs in DNA & RNA, which are “turned off” or “turned on”, through chemical reactions contrary to being affected by changes in the nucleotide sequence. Epigenetic alterations result into a change in phenotype, with the genotype of the organism being constant. Epigenetics changes are influenced by different factors, such as age, surrounding environment, lifestyle, disease state, and others.

Epigenetics can possibly be a key component in a worldview change of our comprehension of health and disease and generally change public health policies. Epigenetic modifications are ordinarily utilized amid the advancement and support of various cell composes, however defective epigenetic control can cause enduring harm, prompting tumor and different illnesses ranging from metabolic scatters, for example, diabetes to coronary illness and psychological well-being conditions.

DNA methylation and histone modification, for instance are epigenetic forms wherein the alteration in gene expression is observed without the adjustment in the DNA Sequence. Ascend in tumor pervasiveness; enhanced financing and helps for R&D activities, a flood in an association between scholarly, pharmaceutical, and biotechnology organizations, and expanded utilization of epigenetics in non-Oncology infections are the key factors that impel the development of this market.

Epigenetics is the study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence . Which in turn affects how cells read the genes. Epigenetic modifications can manifest as commonly as the manner in which cells terminally differentiate to end up as skin cells, liver cells, brain cells, etc. Or, epigenetic change can have more damaging effects that can result in diseases like cancer. At least three systems including DNA methylation, histone modification and non-coding RNA (ncRNA)-associated gene silencing are currently considered to initiate and sustain epigenetic change. New and ongoing research is continuously uncovering the role of epigenetics in a variety of human disorders and fatal diseases.


  • Genetics profession
  • Head of the departments
  • Directors and Managers
  • CEO`s of Biotech, Genetics companies
  • Presidents and Vice Presidents
  • Doctors
  • Professors, Associate and Assistant Professors
  • Research Scholars, Young researchers, and enthusiastic students from the related fields.


The global epigenetics showcase was esteemed at US$ 4.63 Billion in 2017 and is expected to achieve US$ 16.50 Billion by 2026, growing at a CAGR of 15.03 % from 2018 to 2026.

North America (US and Canada) is the present pioneer in the worldwide epigenetics market and anticipated that would demonstrate predominance over the forecast period. Higher acknowledgment of more up to date advancements enormous interest in R&D, and developed social insurance framework are the key factors contributing to the strength of this region.

On the other hand, Asia Pacific is anticipated to demonstrate the fastest market growth over the conjecture time frame fundamentally because of expanding human services spending and creating medicinal services framework. Noteworthy CRO activities in hubs, for example, India also feature the rapid pace of Asia Pacific market.

The epigenetics market is fragmented in view of product, application, end user, and topography. In view of the item, it is separated into proteins, kits & assays, instruments, and reagents.

Based on the end user, the market is arranged into academic & research institutes, pharmaceutical organizations, biotechnology companies & contract research organizations (CROs). Geographically, the market is analyzed across North America, Europe (Germany, UK, France, and Rest of Europe), Asia-Pacific (Japan, China, India, and rest of the APAC), and LAMEA.

Our objective to organize the Epigenetics Meetings is to bring the experts and professionals under one roof to discuss the recent researches and advancement in the field of Genetics.



Lexis is organizing Epigenetics Conference in 2019 in London. We organize Genetics and Molecular Biology Meetings like Human Genetics, Stem Cell research, Cell and Gene Therapies, Epigenetics, Proteomics and in Biology like Structural, Molecular, Cell, Plant and Animal.


Conference Name Location Date
Epigenetics Conference 2019 London, UK September 09-10, 2019






Program Overview